World's Best Scientists 2026 revealed!
George P. Canellos

George P. Canellos

D-Index & Metrics

Medicine

D-Index
101
Citations
46834
World Ranking
7857
National Ranking
4094

George P. Canellos publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where George P. Canellos sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 386 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

George P. Canellos D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where George P. Canellos sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

George P. Canellos is affiliated with Harvard University in the United States. Their academic career is linked to this institution, reflecting a connection to one of the major centers in biomedical and clinical research.

This researcher has been recognized as a member of the Association of American Physicians, an acknowledgment reflecting a professional standing in the medical research community.

There are no recent papers or a list of specific publications available to detail their research contributions explicitly. Likewise, there is no information on frequent co-authors or commonly targeted publication venues that would illustrate collaboration patterns or preferred forums for dissemination.

Information about specific fields of study, subfields, or main topics of research linked directly to George P. Canellos is not provided. Similarly, data about book publications or the number of books published under their name is unavailable.

Despite the limited available data on research outputs and thematic focus, the noted affiliation and award indicate involvement in the field of medical science with likely engagement in clinical and translational research activities.

Best Publications

  • A predictive model for aggressive non-Hodgkin's lymphoma

    M. A. Shipp;D. P. Harrington;J. R. Anderson;J. O. Armitage

  • Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

    B D Cheson;S J Horning;B Coiffier;M A Shipp

  • Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

    T A Lister;D Crowther;S B Sutcliffe;E Glatstein

  • Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD

    G P Canellos;J R Anderson;K J Propert;N Nissen

  • Dose: A Critical Factor in Cancer Chemotherapy

    Emil Frei;George P. Canellos

  • Advanced diffuse histiocytic lymphoma, a potentially curable disease.

    VincentT. Devita;GeorgeP. Canellos;Bruce Chabner;Philip Schein

  • Cancer of the breast: the past decade (first of two parts).

    I C Henderson;G P Canellos

  • Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial

    David B. Duggan;Gina R. Petroni;Jeffrey L. Johnson;John H. Glick

  • Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.

    Vincent T. Devita;Richard M. Simon;Susan M. Hubbard;Robert C. Young

  • Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer.

    Vincent T. Devita;Robert C. Young;George P. Canellos

  • Chronic granulocytic leukemia.

    George P. Canellos

  • Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.

    Philip S. Schein;Vincent T. DeVITA;Susan Hubbard;Bruce A. Chabner

  • Burnout syndrome in the practice of oncology: results of a random survey of 1,000 oncologists.

    D A Whippen;G P Canellos

  • Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy.

    J. C. Arseneau;R. W. Sponzo;D. L. Levin;L. E. Schnipper

  • Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).

    Arthur T. Skarin;George P. Canellos;David S. Rosenthal;Delvyn C. Case

  • Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and Prednisone

    Charles M. Bagley;Vincent T. Devita;Costan W. Berard;George P. Canellos

  • Long-Term Survival and Competing Causes of Death in Patients With Early-Stage Hodgkin’s Disease Treated at Age 50 or Younger

    Andrea K. Ng;M. Patricia Bernardo;Edie Weller;Kendall H. Backstrand

  • SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSION

    George P. Canellos;James C. Arseneau;Vincent T. Devita;Jacqueline Whang-Peng

  • Advanced Ovarian Adenocarcinoma A Prospective Clinical Trial of Melphalan (L-PAM) Versus Combination Chemotherapy

    Robert C. Young;Bruce A. Chabner;Susan P. Hubbard;Richard I. Fisher

  • Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD.

    Margaret A. Shipp;David P. Harrington;Mary M. Klatt;Maxine S. Jochelson

Frequent Co-Authors

Vincent T. DeVita
Vincent T. DeVita Yale University
Bruce A. Chabner
Bruce A. Chabner Harvard University
Jeffrey L. Johnson
Jeffrey L. Johnson LAC+USC Medical Center
Peter Mauch
Peter Mauch Brigham and Women's Hospital
Bruce D. Cheson
Bruce D. Cheson Georgetown University
Donna Niedzwiecki
Donna Niedzwiecki Duke University
Lawrence N. Shulman
Lawrence N. Shulman University of Pennsylvania
Margaret A. Shipp
Margaret A. Shipp Harvard University
Costan W. Berard
Costan W. Berard St. Jude Children's Research Hospital
Robert C. Young
Robert C. Young Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways and advanced credentials is crucial for anyone considering a career in healthcare or aiming to deepen their expertise. The U.S. offers a variety of flexible online options to suit both clinical and non-clinical ambitions. For nurses looking to advance into leadership or specialized practice, pursuing one of the best dnp programs online can be a strategic move. This credential is ideal for those striving to impact patient care at the highest level.

Pharmacists can now take advantage of a 3 year online pharmd program, which accelerates preparation while maintaining flexibility for working professionals. Meanwhile, the intersection of healthcare and technology is rapidly growing, making a degree in health informatics highly valuable for those interested in data-driven decision making.

Not all healthcare roles require a doctoral degree. Starting with affordable medical billing and coding programs can launch a rewarding career in administrative support, which is essential to the smooth operation of medical facilities. Each of these online pathways can help build a meaningful career in the diverse field of U.S. medicine.

Best Scientists Citing George P. Canellos

Trending Scientists

Recently Published Articles